Approval · Notice of Compliance 23745 · 2020
ADVIL COLD & SINUS: Notice of Compliance 23745
Issued June 5, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23745
- Date
- June 5, 2020
- Company
- Glaxosmithkline Consumer Healthcare UlcMississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL COLD & SINUS | Not yet assigned | — |
| ADVIL COLD & SINUS DAYTIME | Not yet assigned | — |
| ADVIL COLD & SINUS LIQUI-GELS | Not yet assigned | — |
| CHILDREN'S ADVIL COLD | Not yet assigned | — |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB
- PSEUDOEPHEDRINE HCL 30 MG per TAB
- IBUPROFEN 200 MG per CAP
- PSEUDOEPHEDRINE HCL 30 MG per CAP
- IBUPROFEN 100 MG per 5ML
- PSEUDOEPHEDRINE HCL 15 MG per 5ML